These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1372103)

  • 1. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Yuba S; Okada Y
    Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three nonsense mutations responsible for group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
    Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of group A xeroderma pigmentosum: a missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene.
    Satokata I; Tanaka K; Okada Y
    Hum Genet; 1992 Mar; 88(6):603-7. PubMed ID: 1339397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
    Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
    Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-site mutation in the XPAC gene alters photoproduct recognition.
    McDowell ML; Nguyen T; Cleaver JE
    Mutagenesis; 1993 Mar; 8(2):155-61. PubMed ID: 8464385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
    Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
    Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
    Sato M; Nishigori C; Yagi T; Takebe H
    Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
    Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
    Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
    Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
    Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
    States JC; Myrand SP
    Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
    Mimaki T; Tanaka K; Nagai A; Mino M
    Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a splicing mutation in group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Miura N; Miyamoto I; Satoh Y; Kondo S; Okada Y
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9908-12. PubMed ID: 1702221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the tumor suppressor gene p53 in xeroderma pigmentosum fibroblasts.
    Lavu S; Srivastava M; Srivastava SK
    Cancer Lett; 1994 Sep; 85(1):9-12. PubMed ID: 7923108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of ultraviolet-induced mutations in a xeroderma pigmentosum cell line.
    Dorado G; Steingrimsdottir H; Arlett CF; Lehmann AR
    J Mol Biol; 1991 Jan; 217(2):217-22. PubMed ID: 1992158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of xpac protein, the gene product of the human XPAC (xeroderma pigmentosum group A complementing) gene.
    Miura N; Miyamoto I; Asahina H; Satokata I; Tanaka K; Okada Y
    J Biol Chem; 1991 Oct; 266(29):19786-9. PubMed ID: 1918083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
    Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
    Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line.
    Jones CJ; Cleaver JE; Wood RD
    Nucleic Acids Res; 1992 Mar; 20(5):991-5. PubMed ID: 1549511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
    Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
    Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.